MedPage Today on MSN
FDA Approves First Farxiga Generics for Type 2 Diabetes
Generics gain indications for glycemic control, reducing heart failure hospitalization ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...
The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide injection, ...
Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results